Position in EYPT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,019,210
-$13,813,849 QoQ
Shares Held
699,706
-44.0% QoQ
Ownership
0.835%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 99.9464060619746.ToString("F0")%
Shared 0.ToString("F0")%
None 0.05359393802539924.ToString("F0")%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Derivatives in EYPT
reported options exposure · as of Mar 31, 2026CallValue
$903,589
CallShares
70,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. EYPT ranks #145 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in EYPT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $903,589 | 70,100 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $9,019,210 | 699,706 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $22,833,059 | 1,249,757 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $21,567,988 | 1,514,606 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $12,051,310 | 1,280,692 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,301,033 | 1,531,556 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $12,385,035 | 1,662,421 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $9,710,469 | 1,215,328 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,886,119 | 791,508 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $17,352,010 | 839,478 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $13,126,156 | 567,986 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $4,797,786 | 600,474 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $3,715,343 | 427,051 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $2,065,590 | 702,582 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $2,669,761 | 762,789 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $6,744,895 | 852,705 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $6,985,663 | 887,632 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $10,583,877 | 871,101 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,613,500 | 622,018 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $407,349 | 39,093 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $2,185,810 | 243,138 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,400,423 | 137,837 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||